References
1. Messé, S. R. et al. Practice advisory update summary: Patent foramen ovale and secondary stroke prevention. Neurology (2020) doi:10.1212/wnl.0000000000009443.
2. Pristipino, C. et al. European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism. Eur. Heart J. (2019) doi:10.1093/eurheartj/ehy649.
3. Silvestry, F. E. et al. Guidelines for the Echocardiographic Assessment of Atrial Septal Defect and Patent Foramen Ovale: From the American Society of Echocardiography and Society for Cardiac Angiography and Interventions. J. Am. Soc. Echocardiogr. (2015) doi:10.1016/j.echo.2015.05.015.
4. Mancini, M. E., Muratori, M., Agostoni, P. & Trabattoni, D. When a patent foramen ovale device is no more in place: silent patent foramen ovale occluder device migration to the aortic arch. Eur. Hear. J. - Case Reports 3 , (2019).
5. Goel, S. S., Aksoy, O., Tuzcu, E. M., Krasuski, R. A. & Kapadia, S. R. Embolization of patent foramen ovale closure devices: Incidence, role of imaging in identification, potential causes, and management.Texas Hear. Inst. J. (2013).
6. Vitarelli, A. et al. Echocardiographic findings in simple and complex patent foramen ovale before and after transcatheter closure.Eur. Heart J. Cardiovasc. Imaging (2014) doi:10.1093/ehjci/jeu143.
7. Bartel, T., Bonatti, J. O. & Müller, S. Device Dislocation, Probably Due to Paroxysmal Coughing Early After Percutaneous Closure of Secundum Type Atrial Septal Defect. Am. J. Cardiol. (2008) doi:10.1016/j.amjcard.2007.08.059.
8. Schoof, S., Norozi, K., Breymann, T., Wessel, A. & Bertram, H. Cough a potentially life-threatening condition after interventional closure of atrial septal defect. Circ. Cardiovasc. Imaging (2009) doi:10.1161/CIRCIMAGING.108.808873.
9. Devendra, G. P., Rane, A. A. & Krasuski, R. A. Provoked exercise desaturation in patent foramen ovale and impact of percutaneous closure.JACC Cardiovasc. Interv. (2012) doi:10.1016/j.jcin.2012.01.011.